SHANGHAI RIGHTONGENE BIOTECHNOLOGYSHANGHAI RIGHTONGENE BIOTECHNOLOGYSHANGHAI RIGHTONGENE BIOTECHNOLOGY

SHANGHAI RIGHTONGENE BIOTECHNOLOGY

No trades
See on Supercharts

688217 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. It offers leukemia-related fusion gene, human estimated glomerular filtration rate gene mutation, genotype, human rubella virus, small ureaplasma, herpes simplex virus type 12 nucleic acid, and hepatitis B virus gene mutation detection kits. The company was founded by Hui Xiong on February 17, 2012 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688217 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company